Ligand validation:6FJE

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6FJE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
6FJE_NAG_A_1644	87%	66%	0.082	0.953	0.44	0.87	-	-	0	100%	0.9333
6FJE_NAG_B_1444	83%	59%	0.09	0.947	0.51	1.05	-	1	1	100%	0.9333
6FJE_NAG_A_1357	79%	60%	0.102	0.949	0.3	1.22	-	2	0	100%	0.9333
6FJE_NAG_A_1471	78%	62%	0.1	0.941	0.31	1.14	-	-	1	100%	0.9333
6FJE_NAG_A_1444	75%	60%	0.098	0.93	0.5	1.02	-	1	0	100%	0.9333
6FJE_NAG_B_1644	69%	64%	0.117	0.932	0.49	0.87	-	1	0	100%	0.9333
6FJE_NAG_B_1471	63%	73%	0.135	0.93	0.33	0.71	-	-	0	100%	0.9333
6FJE_NAG_A_1236	49%	62%	0.142	0.887	0.46	0.99	-	1	0	100%	0.9333
6FJE_NAG_B_1357	44%	69%	0.174	0.903	0.3	0.88	-	-	0	100%	0.9333
6FJE_NAG_A_1483	37%	70%	0.206	0.904	0.35	0.78	-	1	0	100%	0.9333
6FJE_NAG_B_1555	24%	56%	0.207	0.838	0.49	1.18	-	1	0	100%	0.9333
6FJE_NAG_A_1052	19%	60%	0.267	0.862	0.21	1.31	-	3	0	100%	0.9333
6FJE_NAG_B_1483	13%	68%	0.306	0.844	0.29	0.92	-	-	0	100%	0.9333
6FJE_NAG_A_1539	11%	52%	0.315	0.838	0.5	1.32	-	2	0	100%	0.9333
6FJE_NAG_A_1242	10%	59%	0.314	0.826	0.23	1.32	-	2	0	100%	0.9333
6FJE_NAG_A_1512	10%	50%	0.281	0.788	0.26	1.62	-	3	0	100%	0.9333
6FJE_NAG_A_1555	10%	52%	0.247	0.749	0.35	1.47	-	2	0	100%	0.9333
6FJE_NAG_A_1606	9%	51%	0.277	0.766	0.63	1.26	-	2	0	100%	0.9333
6FJE_NAG_B_1236	8%	56%	0.322	0.804	0.42	1.27	-	2	0	100%	0.9333
6FJE_NAG_B_1242	8%	63%	0.356	0.837	0.35	1.03	-	1	0	100%	0.9333
6FJE_NAG_A_1125	8%	40%	0.326	0.801	0.69	1.61	-	4	0	100%	0.9333
6FJE_NAG_B_1319	6%	58%	0.44	0.879	0.41	1.18	-	2	1	100%	0.9333
6FJE_NAG_B_1125	6%	56%	0.307	0.737	0.58	1.12	-	1	0	100%	0.9333
6FJE_NAG_B_1539	5%	47%	0.36	0.775	0.63	1.4	-	2	0	100%	0.9333
6FJE_NAG_B_1052	5%	66%	0.363	0.763	0.32	0.97	-	1	0	100%	0.9333
6FJE_NAG_A_1215	4%	41%	0.402	0.792	0.56	1.72	-	3	0	100%	0.9333
6FJE_NAG_A_1319	4%	32%	0.411	0.785	0.48	2.16	-	5	0	100%	0.9333
6FJE_NAG_B_1215	3%	57%	0.422	0.78	0.46	1.18	-	1	0	100%	0.9333
5O47_NAG_B_1444	91%	65%	0.078	0.964	0.4	0.94	-	1	1	100%	0.9333
6S82_NAG_A_1444	91%	48%	0.084	0.969	0.89	1.13	-	2	0	100%	0.9333
6S3Z_NAG_A_1357	91%	47%	0.088	0.973	0.75	1.28	-	2	0	100%	0.9333
5ANN_NAG_B_1471	89%	60%	0.084	0.962	0.56	0.97	-	1	0	100%	0.9333
5FK7_NAG_A_1471	88%	56%	0.079	0.955	0.29	1.36	-	4	1	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

6FJE

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6FJE designated by the RCSB